These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

756 related items for PubMed ID: 22522090

  • 21. Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study.
    Rungoe C, Simonsen J, Riis L, Frisch M, Langholz E, Jess T.
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):693-700.e1. PubMed ID: 25086189
    [Abstract] [Full Text] [Related]

  • 22. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
    Lindström L, Lapidus A, Ost A, Bergquist A.
    Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Malignancies in patients with inflammatory bowel disease: a nationwide register study in Finland.
    Jussila A, Virta LJ, Pukkala E, Färkkilä MA.
    Scand J Gastroenterol; 2013 Dec; 48(12):1405-13. PubMed ID: 24131389
    [Abstract] [Full Text] [Related]

  • 25. Colorectal cancer prognosis among patients with inflammatory bowel disease.
    Delaunoit T, Limburg PJ, Goldberg RM, Lymp JF, Loftus EV.
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
    Manninen P, Karvonen AL, Huhtala H, Aitola P, Hyöty M, Nieminen I, Hemminki H, Collin P.
    J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
    [Abstract] [Full Text] [Related]

  • 28. High lifetime risk of cancer in primary sclerosing cholangitis.
    Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR.
    J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991
    [Abstract] [Full Text] [Related]

  • 29. Inflammatory bowel disease in Iran: a review of 457 cases.
    Aghazadeh R, Zali MR, Bahari A, Amin K, Ghahghaie F, Firouzi F.
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1691-5. PubMed ID: 16246187
    [Abstract] [Full Text] [Related]

  • 30. The epidemiology of inflammatory bowel disease.
    Burisch J, Munkholm P.
    Scand J Gastroenterol; 2015 Aug; 50(8):942-51. PubMed ID: 25687629
    [Abstract] [Full Text] [Related]

  • 31. Survival after colorectal cancer in patients with Crohn's disease: A nationwide population-based Danish follow-up study.
    Larsen M, Mose H, Gislum M, Skriver MV, Jepsen P, Nørgård B, Sørensen HT.
    Am J Gastroenterol; 2007 Jan; 102(1):163-7. PubMed ID: 17037994
    [Abstract] [Full Text] [Related]

  • 32. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).
    Henriksen M, Jahnsen J, Lygren I, Sauar J, Schulz T, Stray N, Vatn MH, Moum B, Ibsen Study Group.
    Scand J Gastroenterol; 2006 Sep; 41(9):1037-43. PubMed ID: 16938716
    [Abstract] [Full Text] [Related]

  • 33. Risk of ulcerative colitis and Crohn's disease among offspring of patients with chronic inflammatory bowel disease.
    Orholm M, Fonager K, Sørensen HT.
    Am J Gastroenterol; 1999 Nov; 94(11):3236-8. PubMed ID: 10566721
    [Abstract] [Full Text] [Related]

  • 34. Carcinogenesis in inflammatory bowel disease.
    Herszenyi L, Miheller P, Tulassay Z.
    Dig Dis; 2007 Nov; 25(3):267-9. PubMed ID: 17827953
    [Abstract] [Full Text] [Related]

  • 35. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease.
    Lutgens M, Vermeire S, Van Oijen M, Vleggaar F, Siersema P, van Assche G, Rutgeerts P, Oldenburg B, Dutch Initiative on Crohn and Colitis.
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):148-54.e1. PubMed ID: 25041864
    [Abstract] [Full Text] [Related]

  • 36. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
    Ott C, Obermeier F, Thieler S, Kemptner D, Bauer A, Schölmerich J, Rogler G, Timmer A.
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
    [Abstract] [Full Text] [Related]

  • 37. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN, Wajda A, Blanchard JF.
    Clin Gastroenterol Hepatol; 2008 Jan; 6(1):41-5. PubMed ID: 18063423
    [Abstract] [Full Text] [Related]

  • 38. Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study.
    Høivik ML, Moum B, Solberg IC, Henriksen M, Cvancarova M, Bernklev T, IBSEN Group.
    Gut; 2013 Mar; 62(3):368-75. PubMed ID: 22717453
    [Abstract] [Full Text] [Related]

  • 39. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States.
    Wang YR, Cangemi JR, Loftus EV, Picco MF.
    Am J Gastroenterol; 2013 Mar; 108(3):444-9. PubMed ID: 23295277
    [Abstract] [Full Text] [Related]

  • 40. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.
    Gradel KO, Nielsen HL, Schønheyder HC, Ejlertsen T, Kristensen B, Nielsen H.
    Gastroenterology; 2009 Aug; 137(2):495-501. PubMed ID: 19361507
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.